Before its approval any new drug has to be tested on humans. These studies are required to demonstrate its safety in both healthy and sick humans and its effectiveness for various types of patients.
This platform also carries out translational projects, aimed at accumulating and transferring information between the clinical and basic areas. In Neuron BioPharma these studies concentrate on the development of biomarkers that indicate the beginning of neurodegenerative processes. |
|
 |